Go to:
Logótipo
You are here: Start > Publications > View > Introduction to vimentin and novel approaches
Inauguração da Exposição A Velha Escola Morreu
Publication

Introduction to vimentin and novel approaches

Title
Introduction to vimentin and novel approaches
Type
Another Publication in an International Scientific Journal
Year
2013
Authors
Daniel Pozza
(Author)
FMUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
De Mello, RA
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Indexing
Publicação em Scopus Scopus - 0 Citations
Other information
Authenticus ID: P-009-3N9
Abstract (EN): Intermediate filaments (IFs) are among the main cytoskeleton components in most animal cells, being intermediate in diameter between microtubules and actin filaments. Vimentin is one of the large IFsof eukaryotic cell's cytoskeleton, being the major protein in mesenchymal cells and it is frequently used as a developmental marker of cells and tissues. It may be overexpressed in several cancers, such as lung, breast, head and neck cancer, and sarcomas. Furthermore, vimentin pathways may influence benign disease pathogenesis, such as reumathoid arthritis and Crohn's disease. Thus, this chapter will summarize an overview concerning vimentin's molecular mechanisms and novel approaches.
Language: English
Type (Professor's evaluation): Scientific
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same authors

Targeting HER family in HER2-positive metastatic breast cancer: potential biomarkers and novel targeted therapies (2015)
Another Publication in an International Scientific Journal
Costa Monteiro, IDC; Madureira, P; de Vasconscelos, A; Daniel Pozza; de Mello, RA
Current and future aspects of TIM-3 as biomarker or as potential targeted in non-small cell lung cancer scope: is there a role in clinical practice? (2020)
Another Publication in an International Scientific Journal
De Mello, RA; Zhu, JH; Iavelberg, J; Potim, AH; Simonetti, D; Silva, JA; Castelo Branco, P; Daniel Pozza; Tajima, CC; Tolia, M; Antoniou, G
Comparative cost-effectiveness analysis of avelumab plus axitinib versus pembrolizumab plus axitinib, ipilimumab plus nivolumab, and sunitnib for advanced renal cell carcinoma in the UK Perspective (2020)
Another Publication in an International Scientific Journal
De Mello, RA; Ayoub, E; Castelo Branco, P; De Almeida Zia, VAD; Savio, A; Daniel Pozza; Tadokoro, H; Teich, N
Update in Immunotherapy for Advanced Non-small Cell Lung Cancer: Treatment Sequencing and Best Choices (2023)
Other Publications
Roque, K; Ruiz, R; Mas, L; Daniel Pozza; Vancini, M; Silva, JA; De Mello, RA
What Will We Expect From Novel Therapies to Esophageal and Gastric Malignancies? (2018)
Article in International Scientific Journal
De Mello, RA; Castelo-Branco, L; Castelo-Branco, P; Daniel Pozza; Vermeulen, L; Palacio, S; Salzberg, M; Lockhart, AC

See all (11)

Recommend this page Top
Copyright 1996-2024 © Faculdade de Engenharia da Universidade do Porto  I Terms and Conditions  I Accessibility  I Index A-Z  I Guest Book
Page generated on: 2024-10-18 at 20:49:37 | Acceptable Use Policy | Data Protection Policy | Complaint Portal